Icad Inc's ability to collect accounts receivable sequentially worsen to 3.01, pointing to a challenging and on top of that deteriorating business climate for the Medical Equipment & Supplies industry. Icad Inc's Accounts Receivable average collection period in the Mar 31 2025 quarter, has increased to 121 days, from 120 days, in the Dec 31 2024 quarter.

If we take a look into Healthcare sector 467 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2025 from 1993 to 3123.

What is Receivable Turnover Ratio?
What is Icad Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ICAD Receivables Turnover Ratio	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter
Y / Y Receivable Change	1.72 %	12.75 %	11.31 %	-6.33 %	-11.73 %
Y / Y Revenue Change	-1.61 %	179.81 %	3.54 %	-5.98 %	-14.26 %
Receivable Turnover Ratio (TTM)	3.01	3.04	2.66	2.7	2.71
ICAD's Total Ranking	# 3123	# 1993	# 3145	# 2259	# 2024
Accounts Receivable average collection period days	121	120	137	135	134
Seq. Receivable Change	-8.05 %	33.09 %	0.59 %	-17.38 %	1.92 %
Seq. Revenue Change	9.9 %	5.17 %	-16.15 %	1.51 %	212.56 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 162
Healthcare Sector	# 468
Overall Market	# 3123

Receivable Turnover Ratio Statistics
High	Average	Low
5.2	3.82	2.66
(Sep. 30, 2015)		(Sep 30 2024)

ICAD Company Profile • Back to ICAD Efficiency Comparisons • Compare ICAD Receivables Turnover Ratio to its Competitors

Financial Statements
Icad Inc's Accounts Receivable	$ 7 Millions	Visit ICAD's Balance sheet
Icad Inc's Sales TTM	$ 19 Millions	Visit ICAD's Income Statement
Sources of ICAD's Revenues		Visit ICAD's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ICAD's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ICAD's Growth Rates	ICAD's Roa	ICAD's Inventory Turnover Ratio	ICAD's Dividend Comparisons
ICAD's Profitability Ratios	ICAD's Roi	ICAD's Asset Turnover Ratio	ICAD's Dividend Growth
ICAD's Valuation Ratios	ICAD's Roe	ICAD's Financial Strength Ratios	ICAD's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2025	Receivable at quarter ending Mar 31 2025
Idexx Laboratories Inc	7.69	$ 3,931.236 Millions	$ 511.474 Millions
Alphatec Holdings Inc	7.67	$ 641.907 Millions	$ 83.726 Millions
Irhythm Holdings Inc	7.64	$ 618.231 Millions	$ 80.880 Millions
Aveanna Healthcare Holdings Inc	7.62	$ 2,093.077 Millions	$ 274.610 Millions
Sanara Medtech Inc	7.62	$ 91.485 Millions	$ 12.004 Millions
Exelixis Inc	7.58	$ 2,298.922 Millions	$ 303.341 Millions
Personalis Inc	7.53	$ 85.694 Millions	$ 11.377 Millions
Indivior Pharmaceuticals Inc	7.52	$ 2,059.000 Millions	$ 273.750 Millions
Quest Diagnostics Inc	7.52	$ 10,158.000 Millions	$ 1,350.750 Millions
Vystar Corporation	7.51	$ 0.111 Millions	$ 0.015 Millions
Rhythm Pharmaceuticals Inc	7.47	$ 136.863 Millions	$ 18.310 Millions
Guardant Health Inc	7.47	$ 773.996 Millions	$ 103.666 Millions
Star Equity Holdings Inc	7.45	$ 57.165 Millions	$ 7.672 Millions
Amedisys Inc	7.45	$ 2,371.691 Millions	$ 318.418 Millions
Geovax Labs Inc	7.44	$ 5.591 Millions	$ 0.751 Millions
Ardelyx inc	7.43	$ 361.706 Millions	$ 48.652 Millions
Pediatrix Medical Group Inc	7.43	$ 1,976.177 Millions	$ 265.895 Millions
Sutro Biopharma Inc	7.43	$ 66.434 Millions	$ 8.946 Millions
Intuitive Surgical Inc	7.40	$ 8,713.500 Millions	$ 1,177.250 Millions
Blueprint Medicines Corporation	7.38	$ 562.121 Millions	$ 76.188 Millions
Regenxbio Inc	7.37	$ 156.718 Millions	$ 21.270 Millions
Merus N v	7.33	$ 54.732 Millions	$ 7.465 Millions
Nephros Inc	7.32	$ 14.690 Millions	$ 2.007 Millions
Celldex Therapeutics inc	7.29	$ 7.559 Millions	$ 1.038 Millions
Tactile Systems Technology Inc	7.20	$ 292.605 Millions	$ 40.634 Millions
Maravai Lifesciences Holdings Inc	7.19	$ 241.856 Millions	$ 33.634 Millions
Universal Health Services Inc	7.18	$ 16,084.073 Millions	$ 2,240.089 Millions
Medpace Holdings Inc	7.15	$ 2,156.580 Millions	$ 301.809 Millions
Becton Dickinson And Company	7.14	$ 20,867.000 Millions	$ 2,922.750 Millions
Vaso Corporation	7.13	$ 87.491 Millions	$ 12.264 Millions

Date modified: 2026-08-29T17:23:56+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.